Extended Data Fig. 2: With any breast cancer as the outcome in FinnGen (n = 135,300), adjusted survival curves for estrogen receptor-specific polygenic risk scores (PRS). | Nature Medicine

Extended Data Fig. 2: With any breast cancer as the outcome in FinnGen (n = 135,300), adjusted survival curves for estrogen receptor-specific polygenic risk scores (PRS).

From: Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers

Extended Data Fig. 2

The PRS for any breast cancer showed high correlation with the estrogen receptor-positive PRS (Pearson correlation r = 0.93) and moderate correlation with estrogen receptor-negative PRS (r = 0.54).

Back to article page